Cerespir
New York, US · Founded 2013 · Delaware corporation · 1 known investors
Pharmaceutical company developing novel approach to Alzheimer's disease
Biotech
Founders & leadership
AN
Adrian N. HobdenExecutive Officer, Director
DG
Daniel G. ChainExecutive Officer, Director
SJ
Samuel JesselsonDirector
MJ
Michael JesselsonDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$500KraisedSep 2016 · 2 investors · BiotechnologyRule 506(b)
▶$500KraisedSep 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adrian N. HobdenExecutive Officer, Director
- Daniel G. ChainExecutive Officer, Director
- Samuel JesselsonDirector
- Michael JesselsonDirector
- Offering amount
- $500K
- Amount sold
- $500K
- Proceeds to insiders
- $135K
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.